InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（8 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
8
T+90 胜率
100%
T+90 平均收益
+32.2%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Cohen Raymond W, 董事长兼首席执行官. Director active across 5 companies, notably Axonics, Inc.. Cumulatively, 21 filings have been logged. Breakdown: 2 buys · 8 sells. Total volume traded: €13.3m. History available since 10 May 2021. The latest transaction was disclosed on 26 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Cohen Raymond W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
7,217 股Common SharesSEC:0001193125-26-388306:0
30,864 股Common StockSEC:0001193125-26-275834:0
10,000 股@ US$19.98100.0% 占其流量Common SharesSEC:0001193125-26-132324:0
标准退出：2026年6月24日 (T+90)
44,030 股0Common StockSEC:0001493152-26-002663:0
17,000 股@ US$17.0060.8% 占其流量Common SharesSEC:0000950170-25-113631:0
标准退出：2025年6月5日 (T+90)
35,668 股0Common StockSEC:0000950170-25-102098:0
12,994 股Common SharesSEC:0000950170-25-098339:0
292,731 股@ US$71.0049.5% 占其流量Common StockSEC:0001562180-24-007702:0
25,771 股@ US$14.190.8% 占其流量Common StockSEC:0001562180-24-005843:0
63,400 股0Common StockSEC:0001562180-24-001009:0
20,750 股0Common StockSEC:0001562180-23-000873:0
18,684 股@ US$65.54092.8% 占其流量Common StockSEC:0001562180-23-000495:0
18,100 股@ US$69.49763.1% 占其流量Common StockSEC:0001562180-22-006035:0
50,000 股@ US$60.008.2% 占其流量Common StockSEC:0001562180-22-003045:0
17,787 股@ US$50.41842.5% 占其流量Common StockSEC:0001562180-22-002687:0
43,297 股0Common StockSEC:0001562180-22-001104:0
50,000 股@ US$77.1079.9% 占其流量Common StockSEC:0001562180-21-005938:0
5,000 股Common StockSEC:0001437749-21-016942:0
33,333 股@ US$60.005.0% 占其流量Common StockSEC:0001562180-21-004197:0
32,833 股@ US$55.004.5% 占其流量Common StockSEC:0001562180-21-003684:0
13,109 股@ US$52.98161.7% 占其流量Common StockSEC:0001562180-21-003441:0
21 条申报中的 21 条
About Cohen Raymond W
COHEN RAYMOND W is Président-Directeur Général and also serves as Chief Executive Officer at Axonics, Inc., as well as Director at KESTRA MEDICAL TECHNOLOGIES, LTD., RxSight, Inc., InspireMD, Inc. and Biolife Solutions INC. He has 20 filings in total, and across the recent filings available, the transactions are mainly sales, with 440706 EUR of purchases and 32576237 EUR of sales between 2021-05-12 and 2026-06-18.
